Biopharmaceutical Manufacturing Process Validation and Quality Risk Management
Received Date: Aug 01, 2022 / Accepted Date: Aug 31, 2022 / Published Date: Aug 31, 2022
Abstract
Manufacturing processes for biopharmaceuticals must be designed to produce products that have harmonious quality attributes. This entails removing contaminations and pollutants that include endotoxins, contagions, cell membranes, nucleic acids, proteins, culture media factors, process chemicals, and ligands percolated from chromatography media, as well as product variations, summations, and inactive forms. Manufacturing processes should be validated by applying a scientifically rigorous and well- proved exercise demonstrating that the process, and every piece of outfit used in it, constantly performs as intended, and that the process, when operated within established limits, generates a product that routinely and reliably meets its required quality norms.
Citation: Tadagavadi R (2022) Biopharmaceutical Manufacturing Process Validation and Quality Risk Management. Clin Pharmacol Biopharm, 11: 281. Doi: 10.4172/2167-065X.1000281
Copyright: © 2022 Tadagavadi R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
天美传媒 Access Journals
Article Tools
Article Usage
- Total views: 1377
- [From(publication date): 0-2022 - Jan 10, 2025]
- Breakdown by view type
- HTML page views: 1154
- PDF downloads: 223
